Limit by date

Market introduction and reimbursement: workshop for young EU researchers

On May 11, 2023, international Early Stage Researchers of the PHAST-ETN participated in a joint workshop of Leibniz Health Technologies with the InfectoGnostics Research Campus Jena as part of an engagement week at the Center for Applied Research of the Friedrich Schiller University Jena.

Read more

InfectoGnostics and Partner Nanozoo at DMEA 2023 fair in Berlin

From April 25 to 27, the Digital Medical Expertise & Applications (DMEA), Europe's largest trade fair event in the field of digitalized healthcare, was held in Berlin. Our research campus partner Nanozoo presented itself with an appearance at the Thuringian joint booth.

Read more

New spokesperson team of the BioRegions working group elected

Dr. Julia Schaft from BioRN is supported as the new spokesperson of the BioRegions working group by Dr. Jürgen Walkenhorst LifeScience Nord and Dr. Jens Hellwage (InfectoGnostics/Thuringia).

 

Read more

InfectoGnostics and Partners at 7th AMR Conference in Basel

From March 16-17, InfectoGnostics partners presented current research results and product innovations in the field of infection diagnostics at the 7th AMR Conference in Basel

Read more

Entrepreneurship Day for EU ITN TIPAT Winter School in Jena

Some impressions from the EU ITN TIPAT Winter School in Jena last week. We had the pleasure to organize an Entrepreneurship Day with our startup partners BLINK DX, SmartDyeLivery and Nanozoo in the beautiful new building of BLINK AG.

Read more

Open source: Bioinformatics tools from Jena facilitate phage detection and PCR design

In two scientific publications, InfectoGnostics researchers with participation of Leibniz IPHT recently presented new bioinformatics tools whose open source code can now be used and further developed free of charge. The software What the Phage enables the detection of phages, while ConsensusPrime…

Read more
Using a microarray (left), InfectoGnostics researchers can simultaneously detect antibodies against SARS-CoV-2 (right) and against other infectious agents. (Illustration: InfectoGnostics/BioRender.com)

Test Platform from Thuringia Checks Vaccination Status for Corona, Measles, Diphtheria & Tetanus simultaneously

Scientists at the InfectoGnostics Research Campus Jena have developed a new microarray that can detect antibodies against a wide range of infectious agents. With a single drop of the patient's blood, it is thus possible to test whether the immune system has responded to a vaccination or if there is…

Read more
Wissenschaftler der fzmb GmbH betrachten mehrere "INTER-ARRAY"-Chips. Im Hintergrund ist ein solcher Microarray in Nahaufnahme bei der Auswertung zu sehen. (Foto: fzmb)

INTER-ARRAY test kit can differentiate more than 700 strains of Staphylococcus aureus

InfectoGnostics researchers have developed a test that can detect genetic characteristics of the bacterium Staphylococcus aureus and distinguish between more than 700 strains of this pathogen. Virulence factors and resistance genes, including those of the "multiresistant" variants (MRSA), can be…

Read more

InfectoGnostics and partners at the AMR Conference 2022 in Basel (Switzerland)

Together with its partners, the InfectoGnostics Research Campus participated in the AMR Conference in Basel from April 7 to 8, 2022 and presented scientific results and cooperation concepts from Jena. The AMR Conference is considered one of the most important international conferences that…

Read more

Facilitating microbiome analyses: InfectoGnostics researchers remove irrelevant DNA already during sequencing

InfectoGnostics researchers at Jena University Hospital (JUH) and the Leibniz Institute for Photonic Technology (Leibniz-IPHT) have been able to show how irrelevant human DNA can be sorted out already during sequencing with nanopore systems to enable more precise analyses of microbiomes and bring…

Read more